Utah Medical Products publishes 2025 annual report, net income falls 19%

Reuters04-07

Utah Medical Products publishes 2025 annual report, net income falls 19%

Utah Medical Products annual report for 2025 flagged weaker performance driven by loss of high-pressure sensor demand from former key OEM customer PendoTECH, with sales expected to fall to zero in 2026.
Filshie Clip System faced ongoing US product liability litigation, with 15 of 19 courts dismissing cases in company favor as of March 2026.
Outside US revenue outlook was pressured by loss of largest China distributor for blood pressure monitoring kits, with management expecting sales to that customer to be zero in 2026.
Management projected 2026 revenue could hold near 2025 levels if new business replaces lost OEM and distributor volumes, with gross margin expected to improve as low-margin China sales roll off.
Operating profit outlook for 2026 benefited from Femcare acquisition intangible amortization ending in 1Q 2026, reducing annual G&A expense by about $1.6 million versus 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Utah Medical Products Inc. published the original content used to generate this news brief on April 07, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2625951768?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-07 23:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2625951768","market":"us","top_or_hot":-1,"title":"Utah Medical Products publishes 2025 annual report, net income falls 19%","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Utah Medical Products publishes 2025 annual report, net income falls 19%\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<ul>\n<li>\n          Utah Medical Products annual report for 2025 flagged weaker performance driven by loss of high-pressure sensor demand from former key OEM customer PendoTECH, with sales expected to fall to zero in 2026.\n        </li>\n<li>\n          Filshie Clip System faced ongoing US product liability litigation, with 15 of 19 courts dismissing cases in company favor as of March 2026.\n        </li>\n<li>\n          Outside US revenue outlook was pressured by loss of largest China distributor for blood pressure monitoring kits, with management expecting sales to that customer to be zero in 2026.\n        </li>\n<li>\n          Management projected 2026 revenue could hold near 2025 levels if new business replaces lost OEM and distributor volumes, with gross margin expected to improve as low-margin China sales roll off.\n        </li>\n<li>\n          Operating profit outlook for 2026 benefited from Femcare acquisition intangible amortization ending in 1Q 2026, reducing annual G&amp;A expense by about $1.6 million versus 2025.\n        </li>\n</ul>\n<br/>\n<br/>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Utah Medical Products Inc. published the original content used to generate this news brief on April 07, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Utah Medical Products publishes 2025 annual report, net income falls 19%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUtah Medical Products publishes 2025 annual report, net income falls 19%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-04-07 23:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Utah Medical Products publishes 2025 annual report, net income falls 19%\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<ul>\n<li>\n          Utah Medical Products annual report for 2025 flagged weaker performance driven by loss of high-pressure sensor demand from former key OEM customer PendoTECH, with sales expected to fall to zero in 2026.\n        </li>\n<li>\n          Filshie Clip System faced ongoing US product liability litigation, with 15 of 19 courts dismissing cases in company favor as of March 2026.\n        </li>\n<li>\n          Outside US revenue outlook was pressured by loss of largest China distributor for blood pressure monitoring kits, with management expecting sales to that customer to be zero in 2026.\n        </li>\n<li>\n          Management projected 2026 revenue could hold near 2025 levels if new business replaces lost OEM and distributor volumes, with gross margin expected to improve as low-margin China sales roll off.\n        </li>\n<li>\n          Operating profit outlook for 2026 benefited from Femcare acquisition intangible amortization ending in 1Q 2026, reducing annual G&amp;A expense by about $1.6 million versus 2025.\n        </li>\n</ul>\n<br/>\n<br/>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Utah Medical Products Inc. published the original content used to generate this news brief on April 07, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2413666699.HKD","symbol_name":"BNP PARIBAS GLOBAL ENVIRONMENT \"CRH\" (HKDHDG) INC","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nNDLbSD96h:1","article_id":"2625951768","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2625951768","pubTimestamp":1775574380,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Utah Medical Products annual report for 2025 flagged weaker performance driven by loss of high-pressure sensor demand from former key OEM customer PendoTECH, with sales expected to fall to zero in 2026.Filshie Clip System faced ongoing US product liability litigation, with 15 of 19 courts dismissing cases in company favor as of March 2026.Outside US revenue outlook was pressured by loss of largest China distributor for blood pressure monitoring kits, with management expecting sales to that customer to be zero in 2026.Management projected 2026 revenue could hold near 2025 levels if new business replaces lost OEM and distributor volumes, with gross margin expected to improve as low-margin China sales roll off.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investmen","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2413666699.HKD":"BNP PARIBAS GLOBAL ENVIRONMENT \"CRH\" (HKDHDG) INC","IE00BYQQ9H92.USD":"BNY MELLON GLOBAL LEADERS \"A\" (USD) ACC","MTD":"梅特勒-托利多","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4567":"ESG概念","BK4588":"碎股","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","UTMD":"犹他医疗产品","LU2211817866.USD":"Allianz Food Security AT Acc USD","IE00BFXG0V08.USD":"BNY MELLON GLOBAL LEADERS \"B\" (USD) ACC","BK4121":"生命科学工具和服务","LU0347712357.USD":"BNP PARIBAS GLOBAL ENVIRONMENT \"C\" (USD) ACC","LU1721428933.USD":"法巴全球经典环境基金RH MD Dis","LU2413666426.HKD":"BNP PARIBAS GLOBAL ENVIRONMENT \"C\" (HKD) ACC","BK4548":"巴美列捷福持仓","BK4585":"ETF&股票定投概念","BK4198":"医疗保健用品","IE00B5TLWC47.USD":"BNY MELLON LONG-TERM GLOBAL EQUITY \"B\" (USD) ACC"},"translate_title":"犹他医疗产品公司发布2025年年报净利润下降19%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MTD":0.9,"UTMD":0.9},"content_text":"Utah Medical Products publishes 2025 annual report, net income falls 19%\n    \n\n\n          Utah Medical Products annual report for 2025 flagged weaker performance driven by loss of high-pressure sensor demand from former key OEM customer PendoTECH, with sales expected to fall to zero in 2026.\n        \n\n          Filshie Clip System faced ongoing US product liability litigation, with 15 of 19 courts dismissing cases in company favor as of March 2026.\n        \n\n          Outside US revenue outlook was pressured by loss of largest China distributor for blood pressure monitoring kits, with management expecting sales to that customer to be zero in 2026.\n        \n\n          Management projected 2026 revenue could hold near 2025 levels if new business replaces lost OEM and distributor volumes, with gross margin expected to improve as low-margin China sales roll off.\n        \n\n          Operating profit outlook for 2026 benefited from Femcare acquisition intangible amortization ending in 1Q 2026, reducing annual G&A expense by about $1.6 million versus 2025.\n        \n\n\n\n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Utah Medical Products Inc. published the original content used to generate this news brief on April 07, 2026, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2625951768","isCrawlerRequest":true}